Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2QDT

Structural Basis for the Broad-Spectrum Inhibition of Metallo-{Beta}-Lactamases: L1- IS38 Complex

Summary for 2QDT
Entry DOI10.2210/pdb2qdt/pdb
Related2FM6 2FU9 2GKL
DescriptorMetallo-beta-lactamase L1, ZINC ION, SULFATE ION, ... (5 entities in total)
Functional Keywordshydrolase, zn, metallo, lactamase, inhibitor, l1
Biological sourceStenotrophomonas maltophilia
Cellular locationPeriplasm (Potential): P52700
Total number of polymer chains1
Total formula weight29402.09
Authors
Garau, G.,Dideberg, O. (deposition date: 2007-06-21, release date: 2007-08-28, Last modification date: 2024-10-30)
Primary citationLienard, B.M.,Garau, G.,Horsfall, L.,Karsisiotis, A.I.,Damblon, C.,Lassaux, P.,Papamicael, C.,Roberts, G.C.,Galleni, M.,Dideberg, O.,Frere, J.M.,Schofield, C.J.
Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols.
Org.Biomol.Chem., 6:2282-2294, 2008
Cited by
PubMed Abstract: The development of broad-spectrum metallo-beta-lactamase (MBL) inhibitors is challenging due to structural diversity and differences in metal utilisation by these enzymes. Analysis of structural data, followed by non-denturing mass spectrometric analyses, identified thiols proposed to inhibit representative MBLs from all three sub-classes: B1, B2 and B3. Solution analyses led to the identification of broad spectrum inhibitors, including potent inhibitors of the CphA MBL (Aeromonas hydrophila). Structural studies revealed that, as observed for other B1 and B3 MBLs, inhibition of the L1 MBL thiols involves metal chelation. Evidence is reported that this is not the case for inhibition of the CphA enzyme by some thiols; the crystal structure of the CphA-Zn-inhibitor complex reveals a binding mode in which the thiol does not interact with the zinc. The structural data enabled the design and the production of further more potent inhibitors. Overall the results suggest that the development of reasonably broad-spectrum MBL inhibitors should be possible.
PubMed: 18563261
DOI: 10.1039/b802311e
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

245663

数据于2025-12-03公开中

PDB statisticsPDBj update infoContact PDBjnumon